Agilon Health Inc. (NYSE: AGL) reported Q1 EPS of $0.03, $0.03 better than the analyst estimate of $0.00. Revenue for the quarter came in at $1.53 billion versus the consensus estimate of $1.51 billion.

GUIDANCE:

Agilon Health Inc. sees Q2 2025 revenue of $1.43-1.5 billion, versus the consensus of $1.48 billion.

Agilon Health Inc. sees FY2025 revenue of $5.85-6.02 billion, versus the consensus of $5.91 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.